20.07.2016 Carl Zeiss Meditec AG  DE0005313704

DGAP-News: Carl Zeiss Meditec AG: Carl Zeiss Meditec AG announces change to Management Board


 
DGAP-News: Carl Zeiss Meditec AG / Key word(s): Change of Personnel Carl Zeiss Meditec AG: Carl Zeiss Meditec AG announces change to Management Board 20.07.2016 / 11:04 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Carl Zeiss Meditec AG announces change to Management Board Thomas Simmerer will leave the Management Board of Carl Zeiss Meditec AG effective September 30, 2016 Jena, Germany 20 July 2016 Carl Zeiss Meditec AG has announced that Thomas Simmerer, member of the Management Board, has asked the supervisory board to be released from his duties prior to the end of his contract. The supervisory board has agreed to the request and Mr. Simmerer will leave the Management Board effective September 30, 2016. The Management Board of Carl Zeiss Meditec AG will comprise Dr. Ludwin Monz, President and Chief Executive Officer, and Dr. Christian Müller, Chief Financial Officer. The company is planning a change in its organizational structure in order to better serve the relevant Microsurgery and Ophthalmology markets. Contact for the press Jann Gerrit Ohlendorf Director Communications Carl Zeiss Meditec AG Phone: + 49 3641 220-331 Email: [email protected] Contact for investors Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Phone: +49 3641 220-106 Email: [email protected] www.zeiss.com/press --------------------------------------------------------------------------- 20.07.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena Germany Phone: +49 (0)3641 220-0 Fax: +49 (0)3641 220-112 E-mail: [email protected],[email protected] Internet: www.meditec.zeiss.de ISIN: DE0005313704 WKN: 531370 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart; Terminbörse EUREX End of News DGAP News Service --------------------------------------------------------------------------- 484177 20.07.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.189,90 1.280,86 1.459,32 1.335,45 1.646,79 1.902,84 2.089,30
EBITDA1,2 205,07 228,41 313,03 237,98 435,20 466,65 422,19
EBITDA-Marge3 17,23 17,83 21,45 17,82 26,43 24,52
EBIT1,4 180,83 197,13 264,66 177,55 373,61 396,88 348,12
EBIT-Marge5 15,20 15,39 18,14 13,30 22,69 20,86 16,66
Jahresüberschuss1 135,78 126,23 160,58 123,42 237,52 295,91 292,01
Netto-Marge6 11,41 9,86 11,00 9,24 14,42 15,55 13,98
Cashflow1,7 37,73 187,21 219,63 178,53 362,66 188,20 250,86
Ergebnis je Aktie8 1,57 1,41 1,79 1,37 2,64 3,29 3,25
Dividende8 0,55 0,55 0,65 0,50 0,90 1,10 0,42
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Carl Zeiss Meditec
WKN Kurs in € Einschätzung Börsenwert in Mio. €
531370 96,550 Halten 8.635,49
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
27,20 34,97 0,82 47,33
KBV KCV KUV EV/EBITDA
4,19 34,42 4,13 18,39
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,10 1,10 1,14 21.03.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
09.02.2024 08.05.2024 06.08.2024 12.12.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-12,51% 0,44% -2,32% -21,98%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Carl Zeiss Meditec AG  ISIN: DE0005313704 können Sie bei EQS abrufen


Medtech , 531370 , AFX , XETR:AFX